{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-25T02:02:34.885204+00:00","published_at":"2026-10-24T04:45:10.88591+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1qkxtil12pt8n5","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:chen-lichtenstein","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Chen Lichtenstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yh4sqr1ttoctp","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Audit; Compliance; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wcs26tl5612v","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:chen-lichtenstein","alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Chen Lichtenstein member of Audit; Compliance; Finance and Investment, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16il4pua3nihm","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:richard-francis","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Richard Francis seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qjua7njwulnn","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:tal-zaks","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Tal Zaks seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pmydy3154cqy1","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:prof-ronit-satchi-fainaro-tevjf","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"],"summary":"Prof. Ronit Satchi-Fainaro seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:amafiv18a3vuh","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"],"summary":"Compliance; Science and Technology; Corporate Governance and Nominating committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gkw9k01d66ric","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:prof-ronit-satchi-fainaro-tevjf","alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"],"summary":"Prof. Ronit Satchi-Fainaro member of Compliance; Science and Technology; Corporate Governance and Nominating, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mrevx1wuiunr","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:perry-d-nisen","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Perry D. Nisen seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:115afeo15dpnok","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:roberto-mignone","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Roberto Mignone seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11znebih1wwnc","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Corporate Governance and Nominating · Chair; Finance and Investment; Audit committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1i25mb6g79rtu","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:roberto-mignone","alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Roberto Mignone member of Corporate Governance and Nominating · Chair; Finance and Investment; Audit, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wchka51xrdkqv","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Science and Technology; Compliance; Human Resources and Compensation committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:128sitl13fd4jj","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:perry-d-nisen","alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Perry D. Nisen member of Science and Technology; Compliance; Human Resources and Compensation, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ovsdeg1ie5ymm","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:gerald-lieberman","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Gerald Lieberman seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:szo76d14d78it","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:rosemary-a-crane","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Rosemary A. Crane seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:asbc54r2q4wu","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:dr-sol-j-barer","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"],"summary":"Sol J. Barer seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ue1iyg3h291q","event_type":"BOARD_CHAIR_CHANGED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:dr-sol-j-barer","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"],"summary":"Sol J. Barer chairs board TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ib1mkg6zr5xi","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Audit · Chair; Human Resources and Compensation; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qthtw71fbayw9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:gerald-lieberman","alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Gerald Lieberman member of Audit · Chair; Human Resources and Compensation; Finance and Investment, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u1q349muv71x","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Human Resources and Compensation · Chair; Science and Technology committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4ealy1szuse9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:rosemary-a-crane","alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Rosemary A. Crane member of Human Resources and Compensation · Chair; Science and Technology, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1luawxm36983q","event_type":"DIRECTOR_APPOINTED","effective_at":"2009-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:amir-elstein","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Amir Elstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:asgttw1ggs4a2","event_type":"COMMITTEE_CREATED","effective_at":"2009-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment","alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Corporate Governance and Nominating; Audit; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hymqu81ctsfl0","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2009-01-01","detected_at":"2026-10-24T04:45:10.88591+00:00","subject_ids":["alpha:person:amir-elstein","alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment"],"caused_claim_ids":["alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"],"summary":"Amir Elstein member of Corporate Governance and Nominating; Audit; Finance and Investment, effective 2009-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dr-sol-j-barer","object_label":"Sol J. Barer","object_source_name_forms":[],"value":"Sol J. Barer: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dr-sol-j-barer","name":"Sol J. Barer"},"title":"Chairman of the Board","role_category":"director","committee":null,"is_board_chair":true,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2024-04-16T00:00:00+00:00","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amir-elstein","object_label":"Amir Elstein","object_source_name_forms":[],"value":"Amir Elstein: Director, Corporate Governance and Nominating; Audit; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"title":"Director","role_category":"director","committee":"Corporate Governance and Nominating; Audit; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chen-lichtenstein","object_label":"Chen Lichtenstein","object_source_name_forms":[],"value":"Chen Lichtenstein: Director, Audit; Compliance; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"title":"Director","role_category":"director","committee":"Audit; Compliance; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gerald-lieberman","object_label":"Gerald Lieberman","object_source_name_forms":[],"value":"Gerald Lieberman: Director, Audit · Chair; Human Resources and Compensation; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"title":"Director","role_category":"director","committee":"Audit · Chair; Human Resources and Compensation; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:perry-d-nisen","object_label":"Perry D. Nisen","object_source_name_forms":[],"value":"Perry D. Nisen: Director, Science and Technology; Compliance; Human Resources and Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"title":"Director","role_category":"director","committee":"Science and Technology; Compliance; Human Resources and Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","object_label":"Prof. Ronit Satchi-Fainaro","object_source_name_forms":[],"value":"Prof. Ronit Satchi-Fainaro: Director, Compliance; Science and Technology; Corporate Governance and Nominating","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"title":"Director","role_category":"director","committee":"Compliance; Science and Technology; Corporate Governance and Nominating","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2024-04-16T00:00:00+00:00","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-francis","object_label":"Richard Francis","object_source_name_forms":[],"value":"Richard Francis: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-francis","name":"Richard Francis"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roberto-mignone","object_label":"Roberto Mignone","object_source_name_forms":[],"value":"Roberto Mignone: Director, Corporate Governance and Nominating · Chair; Finance and Investment; Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"title":"Director","role_category":"director","committee":"Corporate Governance and Nominating · Chair; Finance and Investment; Audit","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rosemary-a-crane","object_label":"Rosemary A. Crane","object_source_name_forms":[],"value":"Rosemary A. Crane: Director, Human Resources and Compensation · Chair; Science and Technology","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"title":"Director","role_category":"director","committee":"Human Resources and Compensation · Chair; Science and Technology","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tal-zaks","object_label":"Tal Zaks","object_source_name_forms":[],"value":"Tal Zaks: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tal-zaks","name":"Tal Zaks"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.807,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.792,"cross_source_agreement":0.75,"temporal_completeness":0.256},"diagnostics":{"published_claims":53,"factual_claims":53,"claims_with_linked_evidence":53,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":39,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:45:10.88591+00:00","observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":"2026-10-24T04:45:10.88591+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":53,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/teva-pharmaceutical-industries-ltd/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}